Publication | Open Access
Cetuximab plus FOLFOXIRI versus cetuximab plus FOLFOX as conversion regimen in RAS/BRAF wild-type patients with initially unresectable colorectal liver metastases (TRICE trial): A randomized controlled trial
15
Citations
27
References
2024
Year
ClinicalTrials.gov Identifier: NCT03493048.
| Year | Citations | |
|---|---|---|
Page 1
Page 1